Mete Emir Ozgurses

Mete Emir Ozgurses

Auto-generated profile, based on publicly available information

Mete Emir Ozgurses

Department of Physiology and Biophysics, University of Illinois College of Medicine

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2022 in Cell Reports
Verified
Journal Article
Open access
CMCamelia Mocanu
Camelia Mocanu
EKEleftheria Karanika
Eleftheria Karanika
MFMaría Fernández-Casañas
María Fernández-Casañas
AHAlex Herbert
Alex Herbert
TOTomisin Olukoga
Tomisin Olukoga
KCKok-Lung Chan
Kok-Lung Chan
Mitotic DNA synthesis (MiDAS) has been proposed to restart DNA synthesis during mitosis because of replication fork stalling in late interphase caused by mild replication stress (RS). Contrary to this proposal, we find that cells exposed to mild RS in fact maintain continued DNA replication throughout G2 and during G2-M transition in RAD51- and RAD52-dependent manners. Persistent DNA synthesis is necessary to resolve replication intermediates accumulated in G2 and disengage an ATR-imposed block to mitotic entry. Because of its continual nature, DNA synthesis at very late replication sites can overlap with chromosome condensation, generating the phenomenon of mitotic DNA synthesis. Unexpectedly, we find that the commonly used CDK1 inhibitor RO3306 interferes with replication to preclude detection of G2 DNA synthesis, leading to the impression of a mitosis-driven response. Our study reveals the importance of persistent DNA replication and checkpoint control to lessen the risk for severe genome under-replication under mild RS.

18 March 2026 in Nature
Verified
Journal Article
Open access
PDF file
FHFabio Hecht
Fabio Hecht
MZMarco Zocchi
Marco Zocchi
ETEmily T. Tuttle
Emily T. Tuttle
NWNathan P. Ward
Nathan P. Ward
FAFatemeh Alimohammadi
Fatemeh Alimohammadi
IHIsaac S. Harris
Isaac S. Harris
Restricting amino acids from tumours is an emerging therapeutic strategy with substantial promise 1 . Although typically considered an intracellular antioxidant with tumour-promoting capabilities 2 , glutathione (GSH), as a tripeptide of cysteine, glutamate and glycine, can be catabolized to release amino acids. The extent to which GSH-derived amino acids are essential to cancers is unclear. Here we show that depletion of intracellular GSH does not alter tumour growth and extracellular GSH is highly abundant in the tumour microenvironment, highlighting the potential importance of GSH outside tumours. Supplementation with GSH rescues cancer cell survival and growth in cystine-deficient conditions, and this rescue depends on the catabolic activity of γ-glutamyltransferases. Finally, pharmacological targeting of the activity of γ-glutamyltransferases prevents the breakdown of circulating GSH, reduces tumour cysteine levels and slows tumour growth. Our findings indicate a non-canonical role for GSH in supporting tumours by acting as a reservoir of amino acids. Depriving tumours of extracellular GSH or inhibiting its breakdown is potentially a therapeutically tractable approach for patients with cancer. Furthermore, these findings change our view of GSH and how amino acids, including cysteine, are supplied to cells.

23 May 2024 in JCI Insight
Verified
Journal Article
Open access
PDF file
VRVipin Rawat
Vipin Rawat
PDPatrick DeLear
Patrick DeLear
PPPrarthana Prashanth
Prarthana Prashanth
MOMete Emir Ozgurses
Mete Emir Ozgurses
ATAnteneh Tebeje
Anteneh Tebeje
JCJonathan Coloff
Jonathan Coloff
The nonphysiological nutrient levels found in traditional culture media have been shown to affect numerous aspects of cancer cell physiology, including how cells respond to certain therapeutic agents. Here, we comprehensively evaluated how physiological nutrient levels affect therapeutic response by performing drug screening in human plasma-like medium. We observed dramatic nutrient-dependent changes in sensitivity to a variety of FDA-approved and clinically trialed compounds, including rigosertib, an experimental cancer therapeutic that recently failed in phase III clinical trials. Mechanistically, we found that the ability of rigosertib to destabilize microtubules is strongly inhibited by the purine metabolism end product uric acid, which is uniquely abundant in humans relative to traditional in vitro and in vivo cancer models. These results demonstrate the broad and dramatic effects nutrient levels can have on drug response and how incorporation of human-specific physiological nutrient medium might help identify compounds whose efficacy could be influenced in humans.

1 January 2021 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
CMCamelia Mocanu
Camelia Mocanu
MFMaría Fernández-Casañas
María Fernández-Casañas
AHAlex Herbert
Alex Herbert
TOTomisin Olukoga
Tomisin Olukoga
MOMete Emir Ozgurses
Mete Emir Ozgurses
KCKok-Lung Chan
Kok-Lung Chan
Incomplete DNA replication caused by replication stress (RS) has been implicated in chromosome fragility, chromosome mis-segregation and genome instability. To counteract this, an unscheduled DNA synthesis pathway, MiDAS, has been proposed to rescue replication stalling after mitotic entry. It remains unclear why stressed replication forks fail to proceed during late interphase. Here we find that, contrary to the MiDAS model, human cells in fact actively maintain DNA synthesis throughout the entirety of G2 phase in face of mild RS. Besides, the persistent DNA replication activity in G2 is necessary for cells to proceed to mitosis. This is because the passage of unresolved replication structures, either in a retarded or stalled state, from S to G2 activates an ATR-dependent replication-stress checkpoint, blocking mitotic entry. Crucially, G2 DNA synthesis alongside associated G2/M delay creates a feedback mechanism to minimise genome under-replication. Acute inactivation of the RS checkpoint in G2 phase causes severe mitotic chromosome malformation; whereas prolonging G2 DNA synthesis effectively suppresses RS-induced DNA damage in offspring cells. Therefore, our study reveals another important role of G2 phase as an “emergency replication window” and, most importantly, demonstrates the biological necessity of DNA replication outside of S phase. This also offer an explanation for why ATR becomes so vital in G2 uniquely in cells experiencing RS. Understanding the plasticity of the replication programme may provide new insights into how (pre)cancerous cells withstand high intrinsic RS.

15 October 2026
Verified
Other
Open access
PBPhilippa A. Burns
Philippa A. Burns
NTNegar Tabatabaei
Negar Tabatabaei
LSLaura M. Selfors
Laura M. Selfors
HZHuiping Zhao
Huiping Zhao
MSMukhayyo Sultonova
Mukhayyo Sultonova
JCJonathan Coloff
Jonathan Coloff
Serine starvation depletes serine-rich proteins important for mRNA splicing

15 October 2026
Verified
Other
Open access
PBPhilippa A. Burns
Philippa A. Burns
NTNegar Tabatabaei
Negar Tabatabaei
LSLaura M. Selfors
Laura M. Selfors
HZHuiping Zhao
Huiping Zhao
MSMukhayyo Sultonova
Mukhayyo Sultonova
JCJonathan Coloff
Jonathan Coloff
RMATS output for HCC1806 + vs -S/G